The Risk of Malignancy & the Presence of Hürthle Cells with Dr. Carrie Lubitz
Dr. Carrie Lubitz presents the article entitled, "The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates." Dr. Jeffrey Krane joins us as the featured guest discussant. Follow us on Twitter! @thancfoundation - https://shorturl.at/puwS0 THANC on FB - https://shorturl.at/svNY4
▶︎
Dynamic Risk Assessment with Dr. Fabian Pitoia
▶︎
165 Hurthle cell thyroid cancers
▶︎
The Year in Thyroidology: Key Updates with Dr. Davies
▶︎
Thyroid Cytology II: Malignant, SUS, and AUS/FLUS
▶︎
How Long Chemo Side Effects Really Last?
▶︎
Thyroid Nodules What We Know and What We Don't Ultrasound Video
▶︎
Hurthle cell thyroid cancers – these are NOT papillary or follicular thyroid cancers. 322
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎
Radioiodine Avidity in Thyroid Cancer with Dr. Juhlin
▶︎
Thyroid Nodule Guidelines Update Panel Discussion with Dr. Mandel
▶︎
Living With Advanced Thyroid Cancer: Christine's Story
▶︎
The History of Thyroid Cancer Treatment Over the Decades // Fireside Chat
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List
▶︎
Thyroid Ultrasound Course
▶︎
Ask a doctor about papillary, follicular and Hürthle Cell thyroid cancers and variants. 202
▶︎
TSH Suppression & Survival in DTC with Dr. Klubo-Gwiezdzinska
▶︎
Thyroid Cancer Uncovered - A Patient's Guide
▶︎
Small Thyroid Nodules: When to Watch, Biopsy or Treat with Dr. Alexander
▶︎